Expanding bispecific antibody access for multiple myeloma involves collaboration between academic centers and community ...

The latest data released at ASH 2025 offer new combination therapies for the treatment of multiple myeloma and new insights into the disease.

Patients share their unexpected journeys with multiple myeloma, revealing challenges and resilience in the face of a cancer ...

Policy, precision medicine, and new ways of delivering therapeutics were popular topics in 2025 among readers of ...

Dr Rahul Banerjee discusses ASH 2025 and bispecific antibodies in myeloma, including data from MajesTEC-3, IFM2021-01, and ...

Researchers at the Indiana University Melvin and Bren Simon Comprehensive Cancer Center have uncovered biological differences ...

Multiple myeloma is a form of blood cancer you may never have heard of–and that makes sense, because it’s, thankfully, pretty rare. That said, if you’re one of the unlucky few (your average lifetime ...

Patients share their emotional journeys and coping strategies after cancer diagnoses, highlighting the importance of support ...

How Does Talvey Work for Multiple Myeloma? Talvey is a special type of molecule that can attach to two different types of cells. This is called a bispecific antibody. It attaches to GPRC5D proteins on ...

Smoldering multiple myeloma (SMM) is a precancerous condition affecting white blood cells, called plasma cells, in the bone marrow. It can turn into multiple myeloma, a form of blood cancer that can ...

Darzalex (daratumumab) is used for treating a blood cancer called multiple myeloma. Darzalex may be used to treat multiple myeloma that has never been treated, is relapsed, meaning the cancer came ...

House Majority Leader Steve Scalise (R-LA) has been diagnosed with multiple myeloma, a relatively uncommon but treatable blood cancer. Scalise posted a statement on the social media platform X, ...